Heron Therapeutics | HRTX - Betriebsergebnis

Aktienkurs
0.78
Täglich Wechseln
-0.04 -4.74%
Monatlich
-34.57%
Jährlich
-67.29%
Q1 Prognose
0.76




Betriebsergebnis Veränderung Datum
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
Merck USD 6.24B 318M 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 3.19M 9.96M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Surmodics USD -5.64M 276K 2024-09
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12